Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity (Q40782855)

23 September 2017

Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity (English)

1 reference

23 September 2017

0 references

Chang Hee Jung

1

1 reference

23 September 2017

Yu Mi Kang

2

1 reference

23 September 2017

Jung Eun Jang

3

1 reference

23 September 2017

Jenie Yoonoo Hwang

4

1 reference

23 September 2017

Eun Hee Kim

5

1 reference

23 September 2017

Joong-Yeol Park

6

1 reference

23 September 2017

Hong-Kyu Kim

7

1 reference

23 September 2017

Woo Je Lee

8

1 reference

23 September 2017

26 April 2016

1 reference

23 September 2017

1 reference

23 September 2017

24

1 reference

23 September 2017

1373-1379

1 reference

23 September 2017

6

1 reference

Metabolically healthy and unhealthy obese--the 2013 Stock Conference report

23 September 2017

1 reference

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

21 January 2018

1 reference

Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study

21 January 2018

1 reference

The risk of incident type 2 diabetes in a Korean metabolically healthy obese population: the role of systemic inflammation

21 January 2018

1 reference

Diabetes risk among overweight and obese metabolically healthy young adults.

21 January 2018

1 reference

Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications

21 January 2018

1 reference

Characterizing the profile of obese patients who are metabolically healthy

21 January 2018

1 reference

Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome

21 January 2018

1 reference

Metabolically healthy but obese individuals: relationship with hepatic enzymes

21 January 2018

1 reference

Identification and characterization of metabolically benign obesity in humans

21 January 2018

1 reference

Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis.

21 January 2018

1 reference

Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London

21 January 2018

1 reference

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

21 January 2018

1 reference

Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study

21 January 2018

1 reference

Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population.

21 January 2018

1 reference

Coming of age of C-reactive protein: using inflammation markers in cardiology

21 January 2018

1 reference

Standards of medical care in diabetes--2013

21 January 2018

1 reference

Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS).

21 January 2018

1 reference

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

21 January 2018

1 reference

Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese

21 January 2018

1 reference

External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan.

21 January 2018

1 reference

Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals

21 January 2018

1 reference

Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies

21 January 2018

1 reference

Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20).

21 January 2018

1 reference

Evaluation of Cox's model and logistic regression for matched case-control data with time-dependent covariates: a simulation study

21 January 2018

1 reference

Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people

21 January 2018

1 reference

In vivo characterization of the liver fat ¹H MR spectrum

21 January 2018

1 reference

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

The role of hepatokines in metabolism

21 January 2018

1 reference

Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

21 January 2018

1 reference

Plasma fetuin-A levels and the risk of type 2 diabetes

21 January 2018

1 reference

External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/OBY.21483

1 reference

23 September 2017

1 reference